SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving MannKind Corp. and a Lead Plain...
January 22 2016 - 11:44AM
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Central District of
California on behalf of investors who purchased MannKind Corp.
(Nasdaq:MNKD) securities between August 10, 2015 and January 5,
2016.
Click here to learn about the case:
http://docs.wongesq.com/MNKD-Info-Request-Form-1078.
There is no cost or obligation to you. The complaint alleges that
throughout the Class Period Defendants issued false and misleading
statements and/or failed to disclose that: (1) contrary to
Defendants’ assurances, the mandated pulmonary testing or
spirometry was still a significant issue impeding sales of Afrezza,
the Company’s rapid-acting insulin; and (2) as a result,
Defendants’ statements about MannKind’s business, operations, and
prospects, were false and misleading and/or lacked a reasonable
basis at all relevant times.
If you suffered a loss in MannKind you
have until March 15, 2016 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either
via email vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/MNKD-Info-Request-Form-1078.
Vincent Wong, Esq. is an experienced attorney
that has represented investors in securities litigations involving
financial fraud and violations of shareholder rights. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Feb 2024 to Mar 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Mar 2023 to Mar 2024